| (SEK) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 2.21M | — |
| Operating expense | — | — |
| Net income | -142.84M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VICO.ST returned -4.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -6.2% |
| 1 year | -4.3% |
| 5 years | -55.6% |
| 10 years | +25.8% |
| All-time high | kr 31.50 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in VICO.ST would be worth today ›No. Vicore Pharma Holding AB (publ) has not paid a dividend in the past 12 months.
Vicore Pharma Holding AB (publ) is part of the Healthcare sector.
Vicore Pharma Holding AB (publ) has a market cap of 2.98B SEK, based on the latest quote.
Vicore Pharma Holding AB (publ) is scheduled to report earnings on Nov 5, 2026.
